QSA's Week in BioPharma (#4, 2024)

Bill C-368 debates impact NHP industry; Capstone org proposed for research; FNHA joins CAN Health Network; Reproductive health legislation planned; CAN Dental Care covers 2.7M Canadians.

QSA's Week in BioPharma (#4, 2024)

Start Date: 2024-10-26
End Date: 2024-11-01

Top Headlines

Main Stories

Bill C-368 Debated in House of Commons

The House of Commons Standing Committee on Health discussed Bill C-368, which proposes amendments to the Food and Drugs Act affecting natural health products (NHPs). Stakeholders from various organizations voiced concerns about increased fees and new labeling requirements. The Canadian Health Food Association criticized the regulatory changes for being introduced without proper consultation. The Direct Sellers Association expressed support for the bill, noting its potential to address regulatory issues. The discussion also included potential impacts on traditional indigenous medicine and job loss concerns. Witnesses called for balanced regulatory approaches to ensure consumer safety without excessive burdens on small businesses.

Sources: ['Transcripts: parlvu.parl.gc.ca']